Condition: Children · Medical Device · Primary Prevention · Sponsor: Institut Curie
Interest of a Taurolidine lock at each catheter closure in the primary prevention of catheter-related endoluminal infection in paediatric oncology. Multicentric, controlled, randomized and double-blind label study.
This description comes directly from the study's public registry record.
Camille CORDERO, MD · +33172389309 · camille.cordero@curie.fr
Marie-Emmanuelle Legrier, PhD · drci.promotion@curie.fr
Always discuss trial participation with your own doctor first.
| Institut Curie | Paris, France | Recruiting |
| Saint Louis | Paris, France | Recruiting |
| Armand Trousseau | Paris, France | Recruiting |
| Robert Debre | Paris, France | Recruiting |
| Gustave Roussy | Villejuif, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05781295